Vas Narasimhan, CEO Of Novartis: Transforming The Organisation - Outside Lens
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis CEO Vas Narasimhan on M&a and Taking Earlier Risks on New Technology
Novartis agrees $9.7bn deal for US cholesterol drugmaker | Financial Times
Speakers · Total Health · Chicago, October 19-20, 2022
Novartis's new chief sets sights on 'productivity revolution' | Financial Times
CNBC Halftime Report on Twitter: "Today on Halftime, don't miss @MegTirrell's #CNBCExclusive interview with Novartis CEO @VasNarasimhan! #JPM21 https://t.co/kmvOe2V4WJ" / Twitter
New generation pushes AI boundaries - Nikkei Asia
Speakers · Total Health · Chicago, October 19-20, 2022
Johnson & Johnson chief figures Amazon could shake up pharma's distribution, rebates and more | Fierce Pharma
A Year In, Novartis' Boss Faces The World
Committed to growing over 4% through 2026, says Novartis CEO
Vas Narasimhan, CEO Of Novartis: Transforming Standards Of Patient Care - Outside Lens
Digital transformation in the life sciences supply chain – show me the data | Kinaxis
Amazon could partner with a PBM to blaze its trail into pharma: analysts | Fierce Pharma
News: Indian-origin Vasant Narasimhan appointed as the new CEO of Novartis — People Matters
Narasimhan's Culture Club On Song At Novartis :: In Vivo
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Ousted Novartis scientist denies wrongdoing in data manipulation scandal - Super News
Novartis: Vasant Narasimhan ist der jüngste CEO in der Riege - manager magazin
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
The 'student' of leadership who seeks to inspire his employees | Financial Times
Novartis to acquire US-based cancer drugmaker Endocyte for $2.1 billion | Business Standard News